A personalized approach through genetic testing can help identify whether you're a candidate for monotherapy with semaglutide alone
Patients with heart failure, kidney disease, or hypertension should follow their healthcare provider's specific recommendations regarding fluid and sodium intake
Monitoring levels and following your usual hypoglycaemia plan is important
References National Center for Biotechnology Information
Regulatory measures, from the FDAs Compounding Risk Alert to DOJ prosecutions of pharmacies that dispensed unapproved peptides, cement the narrative that access and quality are legitimate issues
These include unexplained fatigue or energy changes, significant mood alterations, palpitations or irregular heartbeat, increased sensitivity to heat or cold, changes in bowel habits beyond expected medication side effects, unexplained hair loss, or skin changes